opentrade on 
↗
↗event3 outcomes
When will the FDA approve Intellia Therapeutics' lonvo-z?
·Science and Technology·ends Jan 8, 2028vol cum
$4.9k
vol 24h
$1.3k
outcomes
3
ends
Jan 8, 2028
outcomesclick to inspect →
marketselected outcome
Before July 2027
rank #1
United States
97¢
▲ 60.0pp
24h change
vol cum
$3.3k
vol 24h
$1.3k
spread
0.56
ends
Jul 8, 2027
If the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jul 1, 2027, then the market resolves to Yes.
timeline
opened · Mar 24, 2026opencloses · Jul 8, 2027
Before July 2027 · prices over time
−24h
now
volume · by outcomehover a column to inspect
no volume history
similar markets
suggested by pdatakalshiWill the FDA approve VERVE-102?
Before 203587¢Before 203481¢· 0.0ppBefore 203276¢
+3 others
$0 24h · 6 markets
polymarketFDA approves Retatrutide this year?
yes3¢▼ 0.6pp
$103 24h · 1 market
The FDA will approve an AI developed cure before the end of the decade (<2030) for a previously incurable major illness.
yes26¢
M0 24h · 1 market
kalshiWhen will the FDA approve Compass Pathways' COMP360 Psilocybin?
Before Mar 1, 202753¢· 0.0ppBefore 202892¢Before October 202790¢
+2 others
$2 24h · 5 markets
polymarketEli Lilly licenses Peptron’s SmartDepot by October 7?
yes13¢
$0 24h · 1 market
Will AOH1996 be FDA approved before 2040?
yes40¢
M0 24h · 1 market